Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses improving MRI testing for patients with prostate cancer.
Andrew Vickers, PhD
Advertisement
Articles by Andrew Vickers, PhD
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the clinical value of MRI testing in prostate cancer.
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the future of MRI in prostate cancer.
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses some potential uses of MRI testing for patients with prostate cancer.
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center discusses studies of the controversial prostate-specific antigen (PSA) test for patients with prostate cancer.
Advertisement
Latest Updated Articles
Expert on Studies of the PSA Test in Prostate CancerPublished: May 19th 2017 | Updated:
Uses of MRI Testing in Prostate CancerPublished: June 23rd 2017 | Updated:
The Future of MRI in Prostate CancerPublished: July 27th 2017 | Updated:
The Clinical Value of MRI Testing in Prostate CancerPublished: August 11th 2017 | Updated:
- Expert Discusses Improving MRI Testing for Prostate Cancer
Published: October 18th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
The OncFive: Top Oncology Articles for the Week of 1/25
2
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5